Heidi combines ambient scribing, point-of-care evidence, and dedicated dictation hardware in a single product family. Support for more than 110 languages and deployment across 190 countries gives the platform broader geographic and linguistic reach than single-market scribe tools.
The company reports more than 2.7 million patient interactions per week and alignment with NHS, GDPR, and HIPAA requirements alongside ISO 27001, SOC 2, Cyber Essentials Plus, and ISO 42001 certifications. This combination of operating scale and compliance posture supports enterprise and public-sector procurement.
Heidi Health, branded as Heidi, is a Melbourne-headquartered company building an AI Care Partner for clinicians. Its portfolio spans the Heidi Scribe ambient documentation product, the Heidi Evidence point-of-care reference product, and the Heidi Remote dictation microphone hardware.
The founding leadership team includes Thomas Kelly as chief executive, Yu Liu as chief technology officer, and Waleed Mussa as chief financial officer, with Simon Kos serving as global chief medical officer. Total disclosed funding stands near US$96.6M after the October 2025 Series B valued the company at US$465M.